GlassScriptPhysician profile
Michael P Savage
NPI 1962425678
$5,585.81
in general payments reported to CMS, 2019-2025
19 companies · $1,114 in 2025
The $1,114 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $823 · 2020: $132 · 2021: $1,254 · 2022: $674 · 2023: $491 · 2024: $1,099 · 2025: $1,114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,703.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,682.34 | 2021-2025 | Symplicity G3, Corevalve Evolut R, Onyx Frontier |
| Abbott Laboratories | $946.90 | 2020-2024 | Coroflow |
| Boston Scientific Corporation | $748.07 | 2019-2025 | Avvigo Guidance System, Opticross, Rotapro |
| Janssen Pharmaceuticals, INC | $437.30 | 2019-2022 | |
| Cardiovascular Systems INC. | $311.29 | 2019-2023 | |
| Edwards Lifesciences Corporation | $297.06 | 2019-2025 | Sapien 3 Ultra Resilia |
| Abiomed | $275.96 | 2019-2024 | Impella |
| Amgen INC. | $200.19 | 2022-2025 | Repatha, Repatha |
| Philips North America LLC | $147.39 | 2019-2023 | |
| Ancora Heart, INC. | $134.47 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $101.95 | 2019-2020 | |
| Biotronik INC. | $92.49 | 2021-2022 | |
| Teleflex LLC | $42.85 | 2019-2025 | Turnpike |
| E.R. Squibb & Sons, L.L.C. | $37.74 | 2024 | Eliquis |
| Medtronic Vascular, INC. | $34.36 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $29.34 | 2021 | |
| Inari Medical, INC. | $23.13 | 2022 | |
| Livanova USA, INC. | $22.92 | 2022 | |
| Angiodynamics, INC. | $20.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Savage listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.